#USA #Tempe #GammaTile #GT Medical Technologies #Goodman Campbell

GT Medical Technologies Announces New GammaTile Center of Excellence

Leading Innovative Care for Brain Tumor Patients

In a significant development in the field of neurosurgery, GT Medical Technologies, renowned for its commitment to improving the quality of life of patients battling brain tumors, has officially recognized Goodman Campbell Brain and Spine – Franciscan Health as the latest GammaTile® Center of Excellence. This designation, announced on July 10, 2025, showcases the center’s exceptional leadership in patient education and clinical expertise in administering the innovative GammaTile procedure.

GammaTile therapy is a revolutionary radiation treatment specifically designed for patients undergoing surgery for brain tumors. It allows physicians to deliver targeted radiation directly to the tumor site immediately after the tumor is removed, enhancing patient outcomes significantly by reducing the chances of cancer recurrence. The innovation has garnered widespread acclaim for its effective approach, which contrasts sharply with conventional treatments requiring a delay before radiation therapy, thus allowing wounds to heal.

Dr. Kushal J. Shah, a distinguished neurosurgeon at Goodman Campbell, expressed pride in the center’s new designation. “Being recognized as a GammaTile provider at Franciscan Health reflects our unwavering commitment to offering the most advanced treatment options available, making a tangible difference in our patients' lives,” he said. Alongside Dr. Shah, Dr. Charles G. Kulwin, also a neurosurgeon practicing at the same institution, has been recognized for his expertise in this groundbreaking procedure.

What is GammaTile?

GammaTile is an FDA-approved, bioabsorbable collagen implant embedded with radiation seeds, strategically placed into the surgical cavity at the time of tumor removal. This process ensures that radiation is administered to the tumor site when cancer cells are most vulnerable. The aim is to inhibit regrowth and minimize exposure to surrounding healthy brain tissue. Such an innovative approach is transforming traditional protocols in brain tumor treatment.

Launched in the United States in March 2020, GammaTile has already seen adoption in more than 100 prominent medical centers, signifying its growing acceptance among both academic and community healthcare providers. This speaks not only to the effectiveness of this technique but also to the urgent need for new solutions in treating brain tumors—a condition that affects numerous individuals and their families.

Commitment to Excellence

The GammaTile Center of Excellence Program recognizes institutions and physicians that meet rigorous clinical criteria relating to their experience with the GammaTile procedure, including a specific annual minimum of cases handled and ongoing education requirements to ensure the highest standard of care. This level of recognition is paramount in promoting continuous improvement in patient care, particularly in such a complex field.

As brain tumor specialists, GT Medical Technologies was founded with the purpose of addressing existing gaps in treatment options. Their dedication is evident through their ongoing research and development of innovative solutions aimed at enhancing the standard of care for patients enduring the challenges of brain tumors.

In conclusion, the designation of Goodman Campbell Brain and Spine as a GammaTile Center of Excellence marks a vital step towards advancing brain tumor treatment. The integration of cutting-edge technology like GammaTile into surgical practices stands to reshape patient outcomes, reduce recurrence rates, and ultimately enhance the quality of life for many.

For further information about the GammaTile technology and its impacts, feel free to explore resources available on GammaTile’s website. Additionally, follow them on social media platforms such as Facebook, Instagram, LinkedIn, and X to stay updated about the latest advancements in brain tumor treatments.

• ---